Envision Healthcare files to sell 27.5M shares of common stock for holders Goldman, Sachs & Co., Barclays, BofA Merrill Lynch and Citigroup are serving as lead joint book-running managers and as representatives of the underwriters for the proposed secondary offering.
BofA/Merrill healthcare high yield analyst has analyst/industry conference call Healthcare High Yield Analyst Bland provides an update on the current state of the bond markets and the ability of healthcare providers to utilize debt financing on an Analyst/Industry conference call to be held on March 24 at 10 am.
Envision Healthcare price target raised to $47 from $40 at Jefferies Jefferies raised its price target for Envision Healthcare shares to $47 and elevated the stock to a Top 5 Pick saying the recent exit of the company's private equity sponsor has eliminated a long-standing overhang. The firm also believes acquisition opportunities in physician services could drive EBITDA and share upside between now and year-end. It keeps a Buy rating on Envision.